Signaling Pathways - MK2 - NPFF receptor - KDR - Adenosine A2A Receptors
清除全部
- C5545 MK2 Inhibitor IVTarget: MK2Summary: 高选择性、非ATP竞争性MK2抑制剂
- B5904 Regadenoson1 Citation中文名: 类伽腺苷Target: Adenosine A2A ReceptorsSummary: A2A腺苷受体激动剂
- B7155 BIBP 3226 trifluoroacetateTarget: NPY Receptors|NPFF receptorSummary: 混合NPY Y1和NPFF受体拮抗剂
- B6995 SCH 58261Target: Adenosine A2A ReceptorsSummary: A2A腺苷受体竞争性拮抗剂
- B6962 CMPD-1Target: Microtubules/Tubulins|MK2Summary: p38α介导的MK2a磷酸化的抑制剂
- B5549 PF-3644022Target: MK2Summary: MK2抑制剂
- B3709 Midostaurin (PKC412)中文名: 米哚妥林Target: PKC|PKA|KDR|Flk1|PPK|c-Syk|CDK1/CyclinBSummary: PKC抑制剂
- B1404 DCC-2036 (Rebastinib)Target: FLT3|Bcr-Abl|Tie-2|KDRSummary: Bcr-Abl抑制剂
- A8454 Istradefylline (KW-6002)中文名: 伊曲茶碱Target: Adenosine A2A ReceptorsSummary: 选择性A2A受体拮抗剂
- A3885 TozadenantTarget: Adenosine A2A ReceptorsSummary: 腺苷2A受体拮抗剂